“…Up till now, large amounts of studies have indicated that treatment with melatonin before and after OGD can exert neuroprotective effects in CNS cells. Detailed characteristics of included studies are shown in Table 1 ( Vlkolinsky and Stolc, 1999 ; Pei and Cheung, 2003 ; Andrabi et al, 2004 ; Uchida et al, 2004 ; Duan et al, 2006 ; Gasparova, Stolc, and Snirc, 2006 ; Han et al, 2006 ; Wang et al, 2009 ; Guo et al, 2010 ; Tai et al, 2011 ; Parada et al, 2014 ; Buendia et al, 2015 ; Huang et al, 2015 ; Patino et al, 2016 ; Suofu et al, 2017 ; Carloni et al, 2018 ; Lin et al, 2018 ; Azedi et al, 2019 ; Beker et al, 2019 ; Liu, Ran, et al, 2019 ; Wei et al, 2019 ; Xing et al, 2019 ; Xiang et al, 2020 ; Yang, Zang, et al, 2020 ; Zhi et al, 2020 ; Liu, Cao, Gao, Li, Xia, et al, 2021 ; Liu, Cao, Gao, Li, Zeng, et al, 2021 ; Nasoni et al, 2021 ; Ran et al, 2021 ; Luchetti et al, 2022 ; Sun et al, 2022 ; Su et al, 2023 ). Lin et al reported that exposure of cultured neurons obtained from the cerebral cortices of Sprague-Dawley rats to 30 min of OGD and 1, 2, 4, and 24 h of reoxygenation caused the increase of cell apoptosis, while pretreatment with melatonin (10–500 µM) before OGD/R for 30 min could promote the survival of neurons (Y.W.…”